|
- Vaccine Adverse Event Reporting System (VAERS)
VAERS is co-sponsored by the Centers for Disease Control and Prevention (CDC), and the Food and Drug Administration (FDA), agencies of the U S Department of Health and Human Services (HHS)
- VAERS Overview | FDA
The Vaccine Adverse Event Reporting System (VAERS) is a valuable tool for post-marketing safety surveillance (monitoring after a product has been approved and is on the market)
- Vaccine Adverse Events Reporting System (VAERS) Help
VAERS data are from a passive surveillance system Such data are subject to limitations of under-reporting, reporting bias, and lack of incidence rates in unvaccinated comparison groups
- VAERS Information - Health. mil
What is VAERS? The Vaccine Adverse Event Reporting System is a national vaccine safety surveillance program administered by the FDA and the CDC VAERS collects and analyzes information about adverse events that occur after the administration of U S licensed vaccines
- FDA Officials Vaccine Claims Alarm Scientists Regulators
VAERS is an early-warning system that collects unverified reports from all sources of adverse events reported after vaccination Anyone can submit a report to VAERS, including patients, family members, healthcare providers, vaccine manufacturers, and the general public
- What it means that the FDA claims Covid vaccines caused child deaths
And it says the deaths were reported to the Vaccine Adverse Event Reporting System, or VAERS, but provides no evidence that the vaccines caused the deaths
- FDA Memo Linking COVID Vaccines to Child Deaths May Boost . . . - KFF
When federal health officials frame unverified [Vaccine Adverse Event Reporting System] reports as evidence of vaccine-caused deaths, it may become more difficult for health communicators to
- Vaccine Adverse Events Reporting System
According to the U S Department of Health and Human Services, “the Vaccine Adverse Event Reporting System (VAERS) is a national early warning system to detect possible safety problems in US-licensed vaccines ”
|
|
|